Michael Ryskin
Stock Analyst at B of A Securities
(0.64)
# 2440
Out of 5,352 analysts
44
Total ratings
45.45%
Success rate
-4.49%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TEM Melco Resorts and En... | Maintains: Neutral | 48 68 | 62.02 | 9.64% | 5 | May 20, 2025 | |
MRVI Maravai LifeSciences | Maintains: Buy | 9 8 | 2.23 | 258.74% | 3 | Mar 3, 2025 | |
IDXX IDEXX Laboratories | Maintains: Neutral | 475 535 | 525.78 | 1.75% | 2 | Feb 4, 2025 | |
ALGN Align Tech | Maintains: Underperform | 200 206 | 179.25 | 14.92% | 6 | Dec 13, 2024 | |
GH Guardant Health | Maintains: Strong Buy | 28 40 | 45.72 | -12.51% | 1 | Jul 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | 5.43 | 74.95% | 1 | Jun 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 9 | n/a | n/a | 2 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 11.48 | 109.06% | 2 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 13.15 | 82.51% | 2 | Jul 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 | n/a | n/a | 2 | Jun 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 225 180 | 170.36 | 5.66% | 7 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 90 | n/a | n/a | 3 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Apr 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 52 | 22.92 | 126.88% | 2 | Nov 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 17 10 | 2.77 | 261.01% | 2 | Nov 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 10 7 | n/a | n/a | 2 | May 14, 2020 |